Daniel Bieri
Development and evaluation of novel PET tracers for imaging cannabinoid receptor type 2 in brain
Slavik R, Bieri D, Cermak S, Müller A, Krämer S, Weber M, Schibli R, Ametamey S, Mu L. Development and evaluation of novel PET tracers for imaging cannabinoid receptor type 2 in brain. Chimia (Aarau) 2014; 68:208-10.
Jan 1, 2014Development and evaluation of novel PET tracers for imaging cannabinoid receptor type 2 in brain
Jan 1, 2014Chimia (Aarau) 2014; 68:208-10
Slavik Roger, Bieri Daniel, Cermak Stjepko, Müller Adrienne, Krämer Stefanie D, Weber Markus, Schibli Roger, Ametamey Simon M, Mu Linjing
Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor
Mu L, Krämer S, Schibli R, Weber M, Cermak S, Müller A, Drandarov K, Slavik R, Bieri D, Ametamey S. Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor. J Neurochem 2013; 126:616-24.
Jul 19, 2013Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor
Jul 19, 2013J Neurochem 2013; 126:616-24
Mu Linjing, Krämer Stefanie D, Schibli Roger, Weber Markus, Cermak Stjepko, Müller Adrienne, Drandarov Konstantin, Slavik Roger, Bieri Daniel, Ametamey Simon M